Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Virginia Commonwealth University